CRWM
BMY icon

Castle Rock Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Castle Rock Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.7M Buy
47,869
+1,506
+3% +$86.5K 0.53% 55
2026
Q1 		$2.76M Buy
46,363
+432
+0.9% +$25.2K 0.6% 44
2025
Q4 		$2.58M Buy
45,931
+56
+0.1% +$2.69K 0.56% 50
2025
Q3 		$2.11M Buy
45,875
+1,316
+3% +$61.5K 0.47% 64
2025
Q2 		$2.09M Buy
44,559
+36,576
+458% +$1.8M 0.49% 50
2025
Q1 		$476K Sell
7,983
-669
-8% -$39K 0.13% 147
2024
Q4 		$466K Sell
8,652
-239
-3% -$13.4K 0.11% 149
2024
Q3 		$482K Sell
8,891
-476
-5% -$22.3K 0.12% 157
2024
Q2 		$387K Buy
9,367
+943
+11% +$42.2K 0.1% 169
2024
Q1 		$372K Buy
8,424
+117
+1% +$5.96K 0.1% 167
2023
Q4 		$433K Buy
8,307
+134
+2% +$7.03K 0.13% 154
2023
Q3 		$463K Buy
8,173
+389
+5% +$23.8K 0.16% 142
2023
Q2 		$504K Hold
7,784
– – 0.17% 127
2023
Q1 		$529K Buy
7,784
+1,111
+17% +$78.4K 0.19% 121
2022
Q4 		$487K Buy
6,673
+853
+15% +$64.3K 0.22% 126
2022
Q3 		$405K Buy
5,820
+3
+0.1% +$218 0.2% 128
2022
Q2 		$437K Buy
5,817
+835
+17% +$63.6K 0.22% 122
2022
Q1 		$381K Buy
4,982
+292
+6% +$19.6K 0.18% 155
2021
Q4 		$298K Buy
4,690
+259
+6% +$15.2K 0.12% 188
2021
Q3 		$263K Sell
4,431
-1,052
-19% -$69.3K 0.09% 220
2021
Q2 		$369K Buy
5,483
+58
+1% +$3.78K 0.14% 182
2021
Q1 		$360K Sell
5,425
-7,611
-58% -$474K 0.15% 187
2020
Q4 		$842K Buy
13,036
+2,977
+30% +$183K 0.35% 95
2020
Q3 		$604K Buy
10,059
+2,582
+35% +$155K 0.4% 87
2020
Q2 		$444K Buy
7,477
+829
+12% +$49.6K 0.26% 124
2020
Q1 		$424K Sell
6,648
-7,303
-52% -$446K 0.37% 73
2019
Q4 		$934K Buy
13,951
+3,032
+28% +$174K 0.84% 31
2019
Q3 		$635K Buy
10,919
+49
+0.5% +$2.3K 0.66% 52
2019
Q2 		$488K Buy
+10,870
New +$506K 0.54% 72

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Castle Rock Wealth Management's BMY Position: Q2 2026 in Review

Castle Rock Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 3.2% in Q2 2026, buying an estimated $86.5K and bringing the position to 47,869 shares worth $2.7M. The position accounts for 0.53% of the portfolio, ranked #55.

Castle Rock Wealth Management first reported a position in BMY in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.76M in Q1 2026. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Castle Rock Wealth Management held 47,869 shares of Bristol-Myers Squibb worth $2.7M as of Q2 2026.
  • Castle Rock Wealth Management bought 1,506 Bristol-Myers Squibb shares in Q2 2026, an estimated $86.5K.
  • Bristol-Myers Squibb made up 0.53% of Castle Rock Wealth Management's portfolio in Q2 2026, its #55 holding.
  • Castle Rock Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 29 quarters since.
  • Castle Rock Wealth Management's Bristol-Myers Squibb position peaked at $2.76M in Q1 2026.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Castle Rock Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.